Brito Mariana, Nunes Gonçalo, Luz Carlos, Oliveira Gabriel, Pinto Marques Pedro, Fonseca Jorge
Department of Gastroenterology, Hospital Garcia de Orta, Almada, Portugal.
PaMNEC - Grupo de Patologia Médica, Nutrição e Exercício Clínico, CiiEM, Centro de investigação interdisciplinar Egas Moniz, Monte da Caparica, Portugal.
GE Port J Gastroenterol. 2022 Apr 28;30(Suppl 1):45-51. doi: 10.1159/000524420. eCollection 2023 Sep.
Anastomotic leak (AL) is a dangerous complication in the early postoperative period after total gastrectomy or esophagectomy being associated with high mortality. Self-expandable metal stents (SEMS) play a significant role in AL management. Only one case report described the use of Mega-Stent in AL setting. The authors report a two-case series with different applications of a Niti-S esophageal Mega-Stent in AL management.
Case 1 is a 67-year-old male who underwent an esophagectomy due to a squamous cell carcinoma of the distal esophagus. The early postoperative period was complicated with AL and gastropleural fistula. Initially, an OTSC was deployed in the dehiscence but failed to resolve AL. The esophageal Mega-Stent was further placed in-between the esophagus and the bulbus. Post-stenting contrast studies confirmed no further AL.Case 2 is an 86-year-old woman who underwent total gastrectomy with roux-en-y esophagojejunostomy due to a gastric adenocarcinoma, complicated with AL. A partially covered metal stent (PCMS) was placed to cover the anastomosis. Computed tomography confirmed leakage persistence and a second PCMS was deployed, resolving the AL. Several weeks later, both PCMSs presented ingrowth from granulation tissue. An esophageal Mega-Stent was placed (stent-in-stent technique) and 2 weeks later, all stents were removed, with no AL recurrence.
DISCUSSION/CONCLUSION: SEMS placement for AL is a safe, well-established therapeutic technique. Limitations include stent migration and incomplete cover of large AL. Mega-Stent can be an emerging tool for endoscopic AL management.
吻合口漏(AL)是全胃切除或食管切除术后早期的一种危险并发症,与高死亡率相关。自膨式金属支架(SEMS)在AL的处理中发挥着重要作用。仅有一篇病例报告描述了在AL情况下使用巨型支架。作者报告了两例系列病例,介绍了Niti-S食管巨型支架在AL处理中的不同应用。
病例1是一名67岁男性,因远端食管鳞状细胞癌接受了食管切除术。术后早期并发AL和胃胸膜瘘。最初,在裂开处放置了OTSC,但未能解决AL问题。随后在食管和球部之间进一步放置了食管巨型支架。支架置入后的造影研究证实没有进一步的AL。病例2是一名86岁女性,因胃腺癌接受了全胃切除及roux-en-y食管空肠吻合术,并发AL。放置了一个部分覆膜金属支架(PCMS)以覆盖吻合口。计算机断层扫描证实渗漏持续存在,于是又放置了第二个PCMS,解决了AL问题。几周后,两个PCMS均出现肉芽组织向内生长。放置了一个食管巨型支架(支架套支架技术),2周后,所有支架均被取出,未出现AL复发。
讨论/结论:SEMS置入治疗AL是一种安全、成熟的治疗技术。其局限性包括支架移位和对大的AL覆盖不完全。巨型支架可能成为内镜下处理AL的一种新兴工具。